Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.

Abstract

BACKGROUND Signal detection is a crucial element in recognising new adverse drug reactions (ADRs) as soon as possible. HMG-CoA reductase inhibitors ('statins'), the most potent cholesterol-lowering drugs, are generally well tolerated but can occasionally lead to liver toxicity. Pre- and postmarketing studies on statins revealed an incidence of 0.1-3… (More)

Topics

  • Presentations referencing similar topics